What are the clinical implications of atrial fibrillation during pregnancy?
Atrial fibrillation during pregnancy can lead to increased risk of thromboembolism, heart failure, and other maternal and fetal complications. Studies have found that the CHA2DS2-VASc and CHADS2 scores can be used to assess the risk of thromboembolism and that transesophageal echocardiography can be used to con rm the clinical utility of these scores. Additionally, anticoagulation therapy can be used to reduce the risk of thromboembolism in patients with atrial fibrillation during pregnancy. Hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy can also be associated with atrial fibrillation during pregnancy. Therefore, it is important to identify and manage atrial fibrillation during pregnancy in order to reduce the risk of maternal and fetal complications. 